Related Experiment Video
Updated: May 15, 2026
11:20
Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
Jumping Over Hurdles: Challenges and Solutions in Phage Therapy
1Department of Medical Microbiology and Parasitology, College of Medicine at Al-Qunfudah, Umm Al-Qura University, Al-Qunfudah, Saudi Arabia.
PHAGE (New Rochelle, N.Y.)
|May 14, 2026
Summary
Bacteriophage therapy offers a promising alternative to antibiotics for multidrug-resistant infections. Advances in phage engineering and personalized approaches enhance its effectiveness, though challenges like resistance and regulation require further research.
Area of Science:
- Microbiology
- Infectious Diseases
- Biotechnology
Background:
- Antimicrobial resistance necessitates novel therapeutic strategies.
- Bacteriophage therapy presents a viable alternative to conventional antibiotics.
- Chronic and multidrug-resistant infections pose significant clinical challenges.
Purpose of the Study:
- To review the current state and future potential of bacteriophage therapy.
- To highlight advancements in phage engineering and personalized treatment approaches.
- To identify challenges and propose future research directions for phage therapy.
Main Methods:
- Review of current literature on bacteriophage therapy.
- Analysis of advancements in phage engineering (genomics, synthetic biology, CRISPR).
- Evaluation of personalized phage therapy and delivery systems.
Main Results:
- Phage therapy shows potential for chronic, multidrug-resistant infections, especially in vulnerable patients.
- Engineered phages exhibit broader host ranges and improved safety.
- Personalized phage therapy demonstrates encouraging clinical outcomes.
- Challenges include regulatory hurdles, safety concerns, and phage resistance.
Conclusions:
- Continued research is crucial to optimize phage therapy protocols and validate efficacy.
- Refining phage engineering, regulatory frameworks, and clinical guidelines are future priorities.
- Global efforts can establish phage therapy as a key tool against antibiotic resistance.
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
00:43Lysogenic Cycle of Bacteriophages
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
01:26DNA Bacteriophages
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
01:16Viral Replication: Lysogenic Cycle
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:20Viral Replication: Lytic Cycle
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...